365 related articles for article (PubMed ID: 9426463)
1. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
2. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
[TBL] [Abstract][Full Text] [Related]
3. Functional studies of E7 proteins from different HPV types.
Ciccolini F; Di Pasquale G; Carlotti F; Crawford L; Tommasino M
Oncogene; 1994 Sep; 9(9):2633-8. PubMed ID: 8058327
[TBL] [Abstract][Full Text] [Related]
4. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
[TBL] [Abstract][Full Text] [Related]
6. E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.
Hiraiwa A; Kiyono T; Suzuki S; Ohashi M; Ishibashi M
Virus Genes; 1996; 12(1):27-35. PubMed ID: 8879118
[TBL] [Abstract][Full Text] [Related]
7. E2F-independent transcriptional repression by p107, a member of the retinoblastoma family of proteins.
Dagnino L; Zhu L; Skorecki KL; Moses HL
Cell Growth Differ; 1995 Feb; 6(2):191-8. PubMed ID: 7756178
[TBL] [Abstract][Full Text] [Related]
8. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
Alevizopoulos K; Sanchez B; Amati B
Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468
[TBL] [Abstract][Full Text] [Related]
9. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
Rampalli AM; Gao CY; Chauthaiwale VM; Zelenka PS
Oncogene; 1998 Jan; 16(3):399-408. PubMed ID: 9467965
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an E2F-p130 complex formed during growth arrest.
Corbeil HB; Branton PE
Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
[TBL] [Abstract][Full Text] [Related]
11. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
12. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of transformation by the human papillomaviruses.
Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
[TBL] [Abstract][Full Text] [Related]
17. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.
Murvai M; Borbély AA; Kónya J; Gergely L; Veress G
Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
19. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
[TBL] [Abstract][Full Text] [Related]
20. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor.
Hilton MJ; Mounghane D; McLean T; Contractor NV; O'Neil J; Carpenter K; Bachenheimer SL
Virology; 1995 Nov; 213(2):624-38. PubMed ID: 7491786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
